Cat. No. | Product name | CAS No. |
DC7962 |
HPOB
Featured
HPOB is a novel selective inhibitor of HDAC6 catalytic activity in vivo and in vitro. |
1429651-50-2 |
DC10837 |
HS-10
Featured
HS-10 is a novel Hsp90 inhibitor increases the Tm of Hsp90 by 10.5°C. |
|
DC12494 |
HS-10296
Featured
HS-10296 is an orally available inhibitor of the epidermal growth factor receptor (EGFR) mutant form T790M, with potential antineoplastic activity. |
1899921-05-1 |
DC12045 |
HS-1371
Featured
HS-1371 is a novel kinase inhibitor of RIP3-mediated necroptosis. |
2158197-70-5 |
DC11128 |
HS148
Featured
HS148 (DAPK3 inhibitor HS148) is a selective DAPK3 inhibitor with Ki of 119 nM, >10-fold selectivity over Pim kinases.. |
1892595-16-2 |
DC7426 |
HS-173
Featured
HS-173 is a potent PI3Kα inhibitor with IC50 of 0.8 nM. |
1276110-06-5 |
DC12632 |
HS220
Featured
HS220 (HS-220) is a Plasmodium-selective takinib analog that targets atypical P. falciparum protein kinase 9 (PfPK9, Kd=4.1 uM) but does not inhibit HsTAK1, decreases K63-linked ubiquitination in P. falciparum; inhibits P. berghei parasite load in HuH7 ce |
1570374-32-1 |
DC10831 |
HS-27
Featured
Hs-27 is a Novel Hsp90 Inhibitor, Exhibits Diagnostic and Therapeutic Potential in Triple Negative Breast Cancer. |
1562024-11-6 |
DC21124 |
HS-38
Featured
HS-38 is a potent and selective DAPK1 and DAPK3 (ZIPK) inhibitor with IC50 of 200 nM for DAPK1 and Kd of 280 nM for ZIPK, also inhibits Pim3 (IC50=200 nM), and displays no activity against Src or Abl, little activity against EGFR; |
1030203-81-6 |
DC11127 |
HS94
Featured
HS94 (DAPK3 inhibitor HS94) is a selective DAPK3 inhibitor with Ki of 126 nM, >20-fold selectivity over Pim kinases.. |
1892594-93-2 |
DC10614 |
HSF1A
Featured
HSF1A is a cell-permeable activator of heat shock transcription factor 1 (HSF1). |
1196723-93-9 |
DC10344 |
HSP70-IN-1
Featured
HSP70-IN-1 is a heat shock protein (HSP) inhibitor; inhibits the growth of Kasumi-1 cells with an IC50 of 2.3 μM. |
1268273-90-0 |
DC4178 |
NVP-HSP990 (HSP990)
Featured
HSP990 is an orally bioavailable inhibitor of human heat-shock protein 90 (Hsp90) with potential antineoplastic activity. |
934343-74-5 |
DC12493 |
HT-2157(SNAP37889)
Featured
HT-2157 (SNAP 37889) is a selective, high-affinity, competitive antagonists of galanin-3 receptor (Gal3). |
303149-14-6 |
DC7705 |
HTH-01-015
Featured
HTH-01-015 is a selective inhibitor of NUAK1 kinase with an IC50 value of 100 nM. |
1613724-42-7 |
DC9960 |
HTHQ
Featured
HTHQ, which is a hydroquinone monoalkyl ether, is a potent anti-oxidative agent, even at low dose levels. |
148081-72-5 |
DC9697 |
HUHS015
Featured
HUHS015 is a prostate cancer antigen (PCA)-1/AlkB homologue 3 (ALKBH3) inhibitor. |
1453097-13-6 |
DC10580 |
hVEGF-IN-1
Featured
hVEGF-IN-1 represses human VEGF-A translation and shows antitumor activity. |
1637443-98-1 |
DC20281 |
Hycanthone
Featured
Hycanthone, the most potent mutagen in a series of nine thiaxanthenones, is a potent inducer of nuclear immunoreactivity to antinucleoside antibodies in HeLa cells. |
3105-97-3 |
DC20410 |
Hydrazinocurcumin
Featured
Hydrazinocurcumin is a synthetic curcumin derivative that inhibits the proliferation of bovine aortic endothelial cells (BAECs) with IC50 of 520 nM without cytotoxicity, inhibits STAT3 phosphorylation and downregulates an array of STAT3 downstream targets. |
131068-23-0 |
DC9614 |
Hydroxyfasudil (hydrochloride)
Featured
Hydroxyfasudil Hcl(HA1100 Hcl), metabolite of Fasudil, is a potent Rho-kinase inhibitor and vasodilator. |
155558-32-0 |
DC20277 |
Hydroxyfasudil free base
Featured
Hydroxy-Fasudil is a metabolite of Fasudil, acting as a potent Rho-kinase inhibitor and vasodilator. |
105628-72-6 |